nvestigators wish to evaluate a new treatment for eclampsia (a life-threatening condition in pregnant women) in women 30 – 50 years of age. the research is intended to directly benefit the pregnant woman who is otherwise healthy and competent. the investigator must obtain consent from whom per subpart b?